These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 8390119

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM, Escaf Barmadah S, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, García Rodríguez J, Rodríguez Faba O, Jalón Monzón A, Rodríguez Martínez JJ.
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE.
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [Abstract] [Full Text] [Related]

  • 9. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T, Goepel M, Seeber S, Rübben H.
    Urologe A; 1993 May; 32(3):189-93. PubMed ID: 7685554
    [Abstract] [Full Text] [Related]

  • 10. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D, Borner M, Sonntag RW, Fey MF, Studer UE.
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Management of localized germ-cell tumours of the testis].
    Loriot Y, Fizazi K.
    Rev Prat; 2007 Feb 28; 57(4):379-84. PubMed ID: 17455739
    [Abstract] [Full Text] [Related]

  • 13. Experience with PVB in non seminomatous germ-cell cancer of the testis.
    Jacquillat C, Auclerc G, Auclerc MF, Verges J, Weil M.
    Prog Clin Biol Res; 1985 Feb 28; 203():451-6. PubMed ID: 2421336
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA.
    Semin Urol; 1993 May 28; 11(2):92-8. PubMed ID: 7689741
    [No Abstract] [Full Text] [Related]

  • 17. Staging and prognostic factors in nonseminomatous testicular cancer.
    Murphy P, Johnson DH.
    Hematol Oncol Clin North Am; 1991 Dec 28; 5(6):1233-43. PubMed ID: 1663942
    [Abstract] [Full Text] [Related]

  • 18. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH, Stein JP, Skinner DG.
    Expert Rev Anticancer Ther; 2005 Feb 28; 5(1):75-85. PubMed ID: 15757440
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.